USPTO serial 79337411
SOLFEN-TECH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 10, 2023
- Examiner
- AGREDA, SAMANTHA LEIGH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SOLFEN-TECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Marcus N. DiBuduo
Marcus N. DiBuduo Fennemore Craig, P.C.8080 N. Palm Ave., Third FloorFresno, CA 93711UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical preparations for pharmaceutical or medical purposes, namely, for providing pain-relief, for wound healing, for providing analgesia, for treating a wound or lesion, for treating a disease caused by a pathogen, for treating or controlling bacterial, viral, fungal and infestational pathogens, and for treating or controlling foot and mouth disease, scabby mouth, hoof rot, footrot, foot abscess and viral lesions; chemical preparations, namely, anaesthetics, local anaesthetics, analgesics, antiseptics and vasoconstrictors; pharmaceutical preparations containing anaesthetic agents, antiseptic agents and vasoconstrictors, namely, topically applied medicated lotions, gels and sprays for treating wounds; pharmaceutical preparations for pain relief; topically applied chemical preparations for pharmaceutical purposes, namely, anaesthetics, local anaesthetics, analgesics, antiseptics and vasoconstrictors; pharmaceutical preparations, namely, topically applied pain-relieving, wound-healing and sterilising preparations; medicated topical gel for providing pain-relief, for wound healing, for providing analgesia, for treating a wound or lesion, for treating a disease caused by a pathogen, for treating or controlling bacterial, viral, fungal and infestational pathogens, and for treating or controlling foot and mouth disease, scabby mouth, hoof rot, footrot, foot abscess and viral lesions; medicated topical lotion for providing pain-relief, for wound healing, for providing analgesia, for treating a wound or lesion, for treating a disease caused by a pathogen, for treating or controlling bacterial, viral, fungal and infestational pathogens, and for treating or controlling foot and mouth disease, scabby mouth, hoof rot, footrot, foot abscess and viral lesions; topically-applied medicated spray for medical and therapeutic treatment of wounds; chemical preparations for pharmaceutical purposes in the form of gels and sprays for providing pain-relief, for wound healing, for providing analgesia, for treating a wound or lesion, for treating a disease caused by a pathogen, for treating or controlling bacterial, viral, fungal and infestational pathogens, and for treating or controlling foot and mouth disease, scabby mouth, hoof rot, footrot, foot abscess and viral lesions; anaesthetic preparations; anaesthetics; local anaesthetic preparations; local anaesthetics; topical anaesthetics; topical anaesthetic preparations in the form of gels and sprays; analgesic preparations; analgesics; topical analgesics; topical analgesic preparations in the form of gels and sprays; topical wound-healing preparations in the form of gels and sprays; topical antiseptic preparations in the form of gels and sprays; animal care products for veterinary use, namely, medicated preparations for providing pain-relief, for wound healing, for providing analgesia, for treating a wound or lesion, for treating a disease caused by a pathogen, for treating or controlling bacterial, viral, fungal and infestational pathogens, and for treating or controlling foot and mouth disease, scabby mouth, hoof rot, footrot, foot abscess and viral lesions; anti-bacterial pharmaceutical preparations; anti-bacterial preparations for veterinary use; antibacterial preparations for medical purposes; anti-inflammatory agents; anti-inflammatory preparations; anti-microbial preparations for treating a wound or lesion, for treating a disease caused by a pathogen, for treating or controlling bacterial, viral, fungal and infestational pathogens, and for treating or controlling foot and mouth disease, scabby mouth, hoof rot, footrot, foot abscess and viral lesions; antiseptic preparations; antiseptics; medicated antiseptic preparations for application to the skin; bactericides for medical and veterinary use; chemical preparations for veterinary purposes, namely, for providing pain-relief, for wound healing, for providing analgesia, for treating a wound or lesion, for treating a disease caused by a pathogen, for treating or controlling bacterial, viral, fungal and infestational pathogens, and for treating or controlling foot and mouth disease, scabby mouth, hoof rot, footrot, foot abscess and viral lesions; cooling sprays for medical purposes; dietary supplements; dietary supplements for animals; disinfectants for use on the person; disinfectants for veterinary use; disinfectants in spray form; disinfecting agents being disinfectants; mineral food supplements for animals; food supplements for animals, being vitamin supplements; food supplements for medical purposes; medicinal food supplements for animals; mineral food supplements; germicides; medical foodstuff additives for veterinary use, namely, animal feed additive for use as a nutritional supplement for medical purposes; medicated additives for animal food, namely, animal feed additives for use as nutritional supplements; medicated animal feed; medicated preparations for the treatment of the skin; medicated supplements for animal feedstuffs; medicated supplements for foodstuffs for animals; microbicides, being antimicrobial preparations for treating wounds; nutritional animal feed supplements; nutritional feed supplements for animals; nutritional supplements for animal feed; nutritional supplements for animals; pain relief medication; medicated pain relieving preparations; medicated pain relieving substances being pain relief medication; medicated preparations for the relief of pain, namely, topical pain-relieving gels and sprays; pharmaceutical preparations for application to the skin being topical medicated skin care preparations; pharmaceutical preparations for application to the body being medicated skin care preparations; pharmaceutical preparations for application to the skin being medicated skin care preparations; preparations for disinfecting skin; medical preparations for care of the skin; medicated preparations for the treatment of the skin; preparations for use in disinfecting; medicated preparations in the form of sprays for the body, namely, for the treatment of wounds; disinfectant sprays of protective film forming material for disinfecting purposes; disinfectant sprays of protective film forming material for medical purposes; veterinary preparations for use in treating the skin; wound healing preparations being pharmaceutical preparations for treatment of wounds; sanitary preparations for medical purposes; medical plasters; materials for dressings being pre-packaged medical dressings pre-moistened with pharmaceutical preparations; medical dressings; medical dressings impregnated with pharmaceutical preparations; medical dressings for skin traumas; dressings for wounds; surgical dressings; surgical dressings being absorbable by the body; surgical dressings carrying substances to increase the rate of healing of the wounds; medical wound dressings for use in cleaning debris from wounds; wound dressing substances being pharmaceutical preparations for the treatment of wounds; bandages for dressings impregnated with pharmaceutical preparations; medicated swabs; medical and surgical swabs; impregnated medicated swabs; medical swabs impregnated with pharmaceutical preparations; medicinal and therapeutic preparations in the nature of disinfectants for the cleaning and debridement of wounds; medicated pre-moistened tissues and wipes; tissues and wipes impregnated with pharmaceutical preparations for treatment of wounds; wound debridement products being pharmaceutical preparations for the treatment of wounds; cleansing pads for medical use, being pre-moistened medicated dressings, tissues and wipes; absorbent pads for medical use, being pre-moistened medicated dressings, tissues and wipes; medicated absorbent pads, being pre-moistened medicated dressings, tissues and wipes; pads for wound cleansing, being pre-moistened medicated dressings, tissues and wipes; sterilising preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 5, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 11, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 11, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 10, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 10, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 10, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 3, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 13, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 13, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 25, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 25, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 13, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 13, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 13, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 5, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 22, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 23, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 23, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 23, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 18, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 31, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 31, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 3, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 2, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 1, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 12, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 8, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 7, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |